학술논문

A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 January 2023, 29(2):331-340)
Subject
Language
English
ISSN
15573265
10780432